Active substance
Results for the substance insulin degludec
2 results
About this active substance
Insulin degludec is an ultra-long-acting insulin analog used to control blood sugar levels in patients with type 1 and type 2 diabetes. It provides stable blood sugar control for 24 hours or longer, reducing the risk of nocturnal hypoglycemia.
The medication is administered as a subcutaneous injection, once daily at the same time, as directed by a doctor. It is important for patients to regularly monitor blood sugar levels and adhere to the treatment regimen.
Patients should be aware of potential side effects, such as hypoglycemia, injection site reactions, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include hypoglycemia, injection site reactions, and weight gain. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before use.
The medication is administered as a subcutaneous injection, once daily at the same time, as directed by a doctor. It is important for patients to regularly monitor blood sugar levels and adhere to the treatment regimen.
Patients should be aware of potential side effects, such as hypoglycemia, injection site reactions, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include hypoglycemia, injection site reactions, and weight gain. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before use.
-
-
TRESIBA 100U/ml solution for injection NOVO NORDISK ORIGINAL MEDICINE